Key findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...
Read moreThe Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...
Read moreThe Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...
Read moreNICE recommends gene therapy for severe beta-thalassaemia, offering hope for improved quality of lif...
Read moreThe Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreIncrease in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreNew doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi...
Read moreGermany's new Medicines Research Act allows confidential rebates for pharma companies, but recent am...
Read moreNew ground-breaking gene therapy for haemophilia B enters NHS England's Innovative Medicines Fund, o...
Read moreThe rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit...
Read more